Skip to main content
OpenTrials
Completed

NCT Number: NCT03049917

Financial Incentives to Increase Pediatric HIV Testing

The purpose of this study is to determine whether giving small financial incentives will motivate parents to test their children for HIV.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kisumu County Hospital

Kisumu, Kenya

About this study

The study will be a randomized controlled trial (RCT) with 5 arms with equal allocation to each arm: no incentive, or one of 4 different levels of financial incentive. We will randomize 800 parents with children of unknown status at HIV treatment clinics in Western Kenya.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Parent/caregiver receiving HIV care
  • Parent/caregiver has one or more children <13 years old
  • Child is HIV exposed (parent/caregiver report or clinic confirmation)
  • Caregiver reports child's HIV status is unknown

Exclusion criteria

  • None
  • The investigators reserve the right to exclude any potential enrollee who is deemed to be at high personal risk, or whose children are at high personal risk, of interpersonal violence, by study participation .

Treatment and study plan

Financial incentive

Behavioral

Conditional cash transfer upon HIV testing

Primary outcomes

  1. Number of Participants Who Present Children for HIV Testing

    Time frame: 2 months

    Number of caregivers who present child(ren) to complete HIV testing at the study clinic within 2 months of recruitment; test results will be recorded in a study questionnaire

  2. Number of Days Participants Take to Bring Children for HIV Testing

    Time frame: 2 months

    Number of days it took between randomization and caregiver presenting the child for HIV testing

Secondary outcomes

  1. Number of Female Participants Who Present Children for HIV Testing (Females)

    Time frame: 2 months

    HIV testing [primary outcome 1] stratified by caregiver sex (females)

  2. Number of Male Participants Who Present Children for HIV Testing

    Time frame: 2 months

    Time to HIV testing [primary outcome 1] stratified by caregiver sex (males)

  3. Number of Caregivers With One Child Who Present Children for HIV Testing

    Time frame: 2 months

    HIV testing [primary outcome 1] stratified by number of children (one child)

  4. Number of Participants With More Than 1 Child Who Present Children for HIV Testing

    Time frame: 2 months

    Number of participants presenting children for HIV testing among caregivers with more than child

  5. Number of Caregivers With Age Less Than Median Presenting Children for HIV Testing

    Time frame: 2 months

    Number of participants presenting for HIV testing stratified by caregiver age (caregiver <=38 years)

  6. Number of Caregivers With Age More Than Median Presenting Children for HIV Testing

    Time frame: 2 months

    Number of caregivers presenting children for HIV testing stratified by caregiver age (caregiver >38 years)

Sponsors and collaborators

Lead sponsor

University of Washington

Other

Collaborators

  • Kenyatta National Hospital
  • University of Nairobi

Registry information

Acronym: FIT

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Feb 10, 2017
Registry last updated
Jun 25, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.